🇺🇸 FDA
Pipeline program

N-Acetylcysteine (NAC)

2007P000095

Phase 2 small_molecule completed

Quick answer

N-Acetylcysteine (NAC) for Radiocontrast Nephropathy is a Phase 2 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
CUMBERLAND PHARMACEUTICALS INC
Indication
Radiocontrast Nephropathy
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials